Marcelo Rubinstein Selected Research

Marcelo Rubinstein Research Topics

Disease

17	Obesity 01/2020 - 07/2002
14	Body Weight (Weight, Body) 04/2024 - 05/2003
7	Morbid Obesity 01/2019 - 11/2012
6	AIDS-Related Complex (ARC) 01/2020 - 06/2003
5	Hyperphagia (Overeating) 01/2020 - 11/2012
4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 02/2024 - 11/2006
4	Insulin Resistance 10/2017 - 04/2010
3	Mental Disorders (Mental Disorder) 02/2024 - 03/2015
3	Hyperinsulinism (Hyperinsulinemia) 12/2016 - 04/2010
3	Glucose Intolerance 12/2016 - 04/2010
2	Alcoholism (Alcohol Abuse) 10/2019 - 01/2018
2	Hyperprolactinemia 12/2016 - 01/2006
2	Hyperglycemia 03/2016 - 11/2012
2	Hypertension (High Blood Pressure) 04/2015 - 05/2002
2	Anorexia 08/2011 - 07/2002
1	Autistic Disorder (Autism) 02/2024
1	Schizophrenia (Dementia Praecox) 02/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 10/2017
1	Weight Loss (Weight Reduction) 10/2017
1	Fatty Liver 12/2016
1	Glycosuria 03/2016
1	Hypokinesia (Bradykinesia) 01/2016
1	Memory Disorders (Memory Loss) 03/2015
1	Bone Marrow Diseases (Bone Marrow Disease) 07/2013
1	Neuroblastoma 07/2013
1	Neoplasm Metastasis (Metastasis) 07/2013
1	Inflammation (Inflammations) 07/2013
1	Neoplasms (Cancer) 07/2013
1	Overweight 11/2012
1	Prolactinoma (Prolactinomas) 01/2006
1	Hyperplasia 01/2006
1	Temporal Lobe Epilepsy 01/2002
1	Seizures (Absence Seizure) 01/2002

Drug/Important Bio-Agent (IBA)

18	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 04/2024 - 06/2003
6	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 04/2010
6	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2006
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 04/2010
5	MelanocortinsIBA 01/2019 - 07/2002
4	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 02/2024 - 11/2006
4	Serotonin (5 Hydroxytryptamine)IBA 10/2017 - 06/2003
4	Insulin (Novolin)FDA Link 12/2016 - 04/2010
4	Peptides (Polypeptides)IBA 03/2016 - 01/2002
3	Antipsychotic Agents (Antipsychotics)IBA 03/2015 - 11/2006
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 01/2016
2	Tamoxifen FDA LinkGeneric 01/2020 - 10/2016
2	LeptinIBA 01/2020 - 10/2016
2	NeuropeptidesIBA 01/2019 - 04/2015
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 12/2016
2	lorcaserinIBA 10/2017 - 10/2014
2	ProlactinIBA 12/2016 - 01/2006
2	Appetite Depressants (Anorectics)IBA 10/2014 - 06/2003
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2006 - 05/2002
1	LigandsIBA 02/2024
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021
1	Guanfacine (Tenex)FDA LinkGeneric 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Leptin ReceptorsIBA 01/2020
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Hypnotics and Sedatives (Sedatives)IBA 10/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 12/2016
1	LipidsIBA 12/2016
1	Sterol Regulatory Element Binding Protein 1IBA 12/2016
1	Melanocortin Receptors (Melanocortin Receptor)IBA 03/2016
1	CatecholaminesIBA 03/2016
1	Epinephrine (Adrenaline)FDA LinkGeneric 03/2016
1	Sodium-Glucose Transport ProteinsIBA 03/2016
1	melanotan-IIIBA 03/2016
1	Blood Glucose (Blood Sugar)IBA 03/2016
1	FenfluramineIBA 10/2014
1	sibutramine (Meridia)FDA Link 10/2014
1	mouse MIRN29 microRNAIBA 07/2013
1	Caspase 8 (Caspase-8)IBA 07/2013
1	CytokinesIBA 07/2013
1	MicroRNAs (MicroRNA)IBA 07/2013
1	Nicotine FDA Link 08/2011
1	Methylphenidate (Ritalin)FDA LinkGeneric 08/2010
1	Haloperidol (Haldol)FDA LinkGeneric 04/2010
1	Cabergoline FDA LinkGeneric 04/2010
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2010
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2002
1	Adenosine Triphosphatases (ATPase)IBA 05/2002
1	Endothelin B ReceptorIBA 05/2002
1	SodiumIBA 05/2002
1	Kainic Acid (Kainate)IBA 01/2002
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2002
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2002

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 10/2014
2	Therapeutics 03/2015 - 07/2013
1	Analgesia 01/2020
1	Glycemic Control 10/2017